Remove Data Remove Media Remove Pets Remove Tincture
article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. and are difficult to predict. cbdMD, Inc. John Weston. Director of Investor Relations.

article thumbnail

cbdMD Therapeutics Announces Launch Of Animal Health Study In Collaboration With Colorado State University’s Veterinary Program

Cannabis Law Report

Study To Explore Effects of cbdMD’s Proprietary Cannabinoid Blend On Pets Who Suffer From Osteoarthritis. The results from this study will provide validating data on the efficacy of the Company’s products in reducing pain and improving joint mobility in dogs. CHARLOTTE, N.C.–(BUSINESS and are difficult to predict.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Consumers Want from CBD Brands

SpeedWeed

The CBD Insider’s 2021 US CBD Consumer Report provides some data around the CBD industry and what consumers want from CBD brands that can help savvy businesses stand out in the marketplace. Based on the data from the study, the breakdown of why U.S. Pets : 5.9%. As the data shows, a large percentage of U.S. Vape : 12.2%.

CBD 52
article thumbnail

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

They may be marketed in ways that put the public health at risk and should especially be kept out of reach of children and pets. The FDA is aware of media reports of delta-8 THC products getting consumers “high.” Delta-8 THC products should be kept out of the reach of children and pets. exposures to any substance(s).

THC 105
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Full report at. Full Letter. Source: [link].

CBD 51
article thumbnail

cbdMD Announces Exclusive Multi-Year Partnership With Amazon Platform Partner Amify

Cannabis Law Report

This partnership includes all the leading and award-winning cbdMD branded products, including cbdMD’s gummies, tinctures, gelcaps and topicals, as well as the award-winning Paw CBD animal brand. The Amify team brings vast expertise to sellers, from branding and advertising to data analytics and business operations. cbdMD, Inc.

article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.fda.gov/media/131878/download.

CBD 144